Covid-19 roundup: Trial of Trump's favorite Covid-19 drug nixed on early death risk; Is Anthony Fauci on thin ice with the president?
A study involving one of President Trump’s favorite Covid-19 drugs had to be halted early after researchers determined that the high dose of the treatment was linked to a higher risk of death.
Brazilian researchers had planned to enlist 440 patients to test chloroquine — closely connected to hydroxychloroquine — in infected patients. But researchers quickly spotted the safety issue. The abstract of their published study concluded:
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
